SECTION 1. Chapter 140 of the General Laws, as appearing in the 2022 Official Edition, is hereby further amended by inserting after Section 174H the following new section:

174I. Selling of animal tested cosmetics.

1. For the purposes of this section the following terms shall have the following meanings:

(a) "Cosmetic", shall mean articles intended to be rubbed, brushed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body or any part thereof for cleaning or for enhancing, concealing or  changing the appearance, including but not limited to personal products such as deodorant, shampoo and conditioner.

(b) "Animal testing", shall mean the internal or  external application of a cosmetic, either in its final form or any ingredient thereof, to the skin, eyes, or other body part of a live non-human vertebrate.

(c) "Ingredient", shall have the same meaning as defined in 21 CFR 700.3(e).

(d)  "Manufacturer", shall mean any person whose name appears on the label of a cosmetic pursuant to the requirements of 21 CFR 701.12.

(e) "Supplier", shall mean any entity that supplies, directly or through a third  party, any  ingredient used by a manufacturer in the formulation of a cosmetic.

2.  Except as otherwise provided in this section, it shall be unlawful for a manufacturer to import for profit, sell or offer for sale in the commnwealth, any cosmetic which the manufacturer knew or reasonably should have known that animal testing was conducted or contracted by or on behalf of the  manufacturer or any supplier of the manufacturer if the animal testing was conducted after the effective date of this section. No provision of this subsection shall be construed to apply to a test method conducted for the purposes of medical research.

3. This section does not apply to animal testing that is conducted:

(a) As a requirement of any federal or state regulatory agency if:

(i) the cosmetic or an ingredient in the cosmetic which is being tested is in wide use and cannot be replaced by another ingredient which is capable of performing a similar function; and

(ii) a specific human health problem relating to the cosmetic or ingredient is substantiated and the need to conduct animal testing is justified and supported by a detailed protocol for research that is proposed as the basis for the evaluation of the cosmetic or ingredient; and

(iii) there does not exist a method of testing other than animal testing that is accepted  for the relevant purpose by a federal or state regulatory agency.

(b) As a requirement of any regulatory agency of a foreign jurisdiction, if no evidence derived  from such testing was relied upon to substantiate the safety of a cosmetic sold within the commonwealth by the manufacturer.

(c) For any product or ingredient in a cosmetic which is subject to the requirements under 21 USC subchapter V.

(d) For purposes not related to cosmetics as required by any federal, state or foreign  regulatory agency, provided that no evidence derived from such testing was relied upon  to  substantiate the safety of a cosmetic sold within the state by the manufacturer, unless:

(i) documentary evidence exists that the intent of the animal testing was unrelated to cosmetics; and

(ii) there is a history of the use of  the ingredient unrelated to cosmetics for a minimum of twelve months.

4. This section does not apply to a cosmetic:

(a)  If, in its final form, such cosmetic was tested on animals before the effective date of this section, even if the cosmetic is manufactured on or after such date.

(b) If an ingredient contained in such cosmetic was tested on animals and sold in the commonwealth before the effective date of this section, even if such ingredient is manufactured on or after such date.

5. This section may not be construed to prevent a manufacturer from reviewing, assessing or retaining data resulting from exempted animal testing or from past animal testing results.

6. The attorney general may, upon a determination that there is a reasonable likelihood of a violation of this section, review any testing data on which a manufacturer has relied in determining the safety of a cosmetic or an ingredient in a cosmetic sold in Massachusetts. Any information related to a trade secret, as defined in section 42 of chapter 93 or 18 U.S.C. § 1839(3) and per Fair Packaging and Labeling Program, 15 U.S.C. § 1454(c)(3), disclosed under this section shall be protected and the attorney general shall enter into a protective order with the manufacturer before receipt of such information.

The attorney general shall take other appropriate measures as necessary to preserve the confidentiality of the information produced pursuant to this section. The attorney general may bring an action or special proceeding in the supreme court for a judgment enjoining the continuance of such violation and for a civil penalty of not more than five thousand dollars for the first violation and not more than one thousand dollars per day if the violation continues.

SECTION 2. This shall take effect 6 months after the passage of this act.